Which has grown faster, LMAT or NTLA?

Over the past five years, LMAT grew revenue faster — LMAT at a 11.76% CAGR versus NTLA at 7.31%.

Does LMAT or NTLA pay a bigger dividend?

LMAT pays a dividend (1.17% yield), while NTLA has no payments in the available dividend history.

Is LMAT or NTLA more profitable?

LMAT runs the higher net margin — LMAT at 25.02% versus NTLA at -672.16%.

How have LMAT and NTLA total returns compared?

Over the past 10 years, LMAT delivered 16.21% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.

LeMaitre Vascular, Inc. (LMAT) vs Intellia Therapeutics, Inc. (NTLA)

A side-by-side comparison of LeMaitre Vascular, Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LMAT

LeMaitre Vascular, Inc.

$1.82B

$79.47HealthcareDelayed quote: Oct 6, 2026, 2:38 PM EDT

NTLA

Intellia Therapeutics, Inc.

$1.74B

$12.43HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT

Total return — LMAT vs NTLA

growth of $100 · dividends reinvested · last 10y

LMAT +344.3% (+16.1%/yr)NTLA -26.5% (-3.0%/yr)LMAT compounded faster over this window

Log scale — wide-divergence pair

LMAT NTLA

LMAT vs NTLA: by the numbers

•LMAT is the larger company ($1.82B vs $1.74B market cap).
•LMAT is profitable (25.02% net margin) while NTLA runs a net loss (-672.16%).
•LMAT grew revenue faster over the past five years (11.76% vs 7.31% CAGR).
•LMAT pays a dividend (1.17% yield), while NTLA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	LMAT	NTLA
P/E ratio	27.88	N/A
Forward P/E	27.66	N/A
PEG ratio	1.44	N/A
P/S ratio	6.92	29.17
P/B ratio	4.32	2.39
EV / EBITDA	21.78	N/A
FCF yield	4.07%	N/A

Profitability

Metric	LMAT	NTLA
Gross margin	72.90%	76.47%
Operating margin	29.46%	-651.67%
Net margin	25.02%	-672.16%
ROE	15.62%	-54.96%
ROIC	9.81%	-54.45%

Dividends

Metric	LMAT	NTLA
Dividend yield	1.17%	N/A
Payout ratio	33.33%	N/A

Growth (annualized)

Metric	LMAT	NTLA
Revenue CAGR (5Y)	11.76%	7.31%
EPS CAGR (5Y)	19.42%	N/A
FCF CAGR (5Y)	13.06%	N/A
Total return CAGR (5Y)	9.79%	-37.13%

Frequently asked

Which has grown faster, LMAT or NTLA?: Over the past five years, LMAT grew revenue faster — LMAT at a 11.76% CAGR versus NTLA at 7.31%.
Does LMAT or NTLA pay a bigger dividend?: LMAT pays a dividend (1.17% yield), while NTLA has no payments in the available dividend history.
Is LMAT or NTLA more profitable?: LMAT runs the higher net margin — LMAT at 25.02% versus NTLA at -672.16%.
How have LMAT and NTLA total returns compared?: Over the past 10 years, LMAT delivered 16.21% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LMAT analysis Full NTLA analysis Interactive comparison tool

Dig into the metrics

LeMaitre Vascular P/E ratio LeMaitre Vascular dividend yield LeMaitre Vascular ROE Intellia Therapeutics ROE LeMaitre Vascular operating margin Intellia Therapeutics operating margin LeMaitre Vascular revenue growth Intellia Therapeutics revenue growth LeMaitre Vascular free cash flow Intellia Therapeutics free cash flow

LeMaitre Vascular & Intellia Therapeutics appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.